Segment Information

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Segment Information

 Segment Information

Our business operations are organized into two reportable segments, which are aligned with the underlying markets and customers they serve. Our reportable segments are Packaging Systems and Delivery Systems. Packaging Systems develops, manufactures and sells primary packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Delivery Systems develops, manufactures and sells safety and administration systems, multi-component systems for drug administration, and a variety of custom contract-manufacturing solutions targeted to the healthcare and consumer-products industries. In addition, Delivery Systems is responsible for the continued development and commercialization of our line of proprietary, multi-component systems for injectable drug administration and other healthcare applications.

Packaging Systems has three operating segments: the Americas, Europe and Asia Pacific. These operating segments are aggregated for reporting purposes as they have common economic characteristics, produce and sell a similar range of products, use a similar distribution process and have a similar customer base. Delivery Systems consists of only one operating segment.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that management considers not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. Corporate assets include pension assets and investments in affiliated companies. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

The following table provides information on sales by significant product group:

($ in millions)	2014			2013			2012
Packaging Systems	$	1,019.7		$	996.0		$	915.1
Proprietary products	105.4			92.7			77.0
Contract manufacturing	297.1			281.4			275.1
Delivery Systems	402.5			374.1			352.1
Intersegment sales elimination	(0.8		)	(1.7		)	(0.8		)
Net sales	$	1,421.4		$	1,368.4		$	1,266.4

The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.

We do not have any customers accounting for greater than 10% of consolidated net sales.

The following table presents sales and net property, plant and equipment, by the country in which the legal subsidiary is domiciled and assets are located:

	Sales						Property, Plant and Equipment, Net
($ in millions)	2014		2013		2012		2014		2013		2012
United States	$	655.5	$	614.5	$	592.8	$	339.4	$	336.0	$	322.0
Germany	219.4		219.6		184.4		110.9		124.4		117.2
France	118.2		112.6		102.6		40.4		43.4		42.1
Other European countries	285.0		279.4		251.4		91.5		83.2		72.3
Other	143.3		142.3		135.2		123.6		124.7		115.4
	$	1,421.4	$	1,368.4	$	1,266.4	$	705.8	$	711.7	$	669.0

The following tables provide summarized financial information for our segments:

($ in millions)	Packaging Systems		Delivery Systems		Corporate and Eliminations			Consolidated
2014
Net sales	$	1,019.7	$	402.5	$	(0.8	)	$	1,421.4
Operating profit	$	223.0	$	13.5	$	(54.5	)	$	182.0
Interest expense, net	—		—		(13.0		)	(13.0		)
Income before income taxes	$	223.0	$	13.5	$	(67.5	)	$	169.0
Segment assets	$	1,024.3	$	405.1	$	241.5		$	1,670.9
Capital expenditures	76.5		35.8		(0.4		)	111.9
Depreciation and amortization expense	58.3		23.0		8.7			90.0
2013
Net sales	$	996.0	$	374.1	$	(1.7	)	$	1,368.4
Operating profit	$	217.0	$	9.4	$	(64.0	)	$	162.4
Loss on debt extinguishment	—		—		(0.2		)	(0.2		)
Interest expense, net	—		—		(15.1		)	(15.1		)
Income before income taxes	$	217.0	$	9.4	$	(79.3	)	$	147.1
Segment assets	$	1,048.9	$	429.3	$	193.4		$	1,671.6
Capital expenditures	81.3		28.5		42.1			151.9
Depreciation and amortization expense	55.5		20.9		8.8			85.2
2012
Net sales	$	915.1	$	352.1	$	(0.8	)	$	1,266.4
Operating profit	$	187.5	$	18.4	$	(70.8	)	$	135.1
Loss on debt extinguishment	—		—		(11.6		)	(11.6		)
Interest expense, net	—		—		(14.9		)	(14.9		)
Income before income taxes	$	187.5	$	18.4	$	(97.3	)	$	108.6
Segment assets	$	942.7	$	389.3	$	232.0		$	1,564.0
Capital expenditures	74.3		24.5		32.5			131.3
Depreciation and amortization expense	52.7		18.4		5.8			76.9

During 2014, we recognized a pre-tax loss on debt extinguishment of less than $0.1 million, in connection with repurchases of our Convertible Debentures. We recognized a pre-tax loss on debt extinguishment of $0.2 million and $11.6 million, during 2013 and 2012 respectively, in connection with similar repurchases.  Refer to Note 8, Debt, for additional details.